{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:06:26Z","timestamp":1790039186406,"version":"4.0.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T00:00:00Z","timestamp":1528329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T00:00:00Z","timestamp":1528329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008967","name":"Bilim Akademisi","doi-asserted-by":"publisher","award":["BAGEP"],"award-info":[{"award-number":["BAGEP"]}],"id":[{"id":"10.13039\/501100008967","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Semant"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Adverse drug reactions (ADRs), also called as drug adverse events (AEs), are reported in the FDA drug labels; however, it is a big challenge to properly retrieve and analyze the ADRs and their potential relationships from textual data. Previously, we identified and ontologically modeled over 240 drugs that can induce peripheral neuropathy through mining public drug-related databases and drug labels. However, the ADR mechanisms of these drugs are still unclear. In this study, we aimed to develop an ontology-based literature mining system to identify ADRs from drug labels and to elucidate potential mechanisms of the neuropathy-inducing drugs (NIDs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We developed and applied an ontology-based SciMiner literature mining strategy to mine ADRs from the drug labels provided in the Text Analysis Conference (TAC) 2017, which included drug labels for 53 neuropathy-inducing drugs (NIDs). We identified an average of 243 ADRs per NID and constructed an ADR-ADR network, which consists of 29 ADR nodes and 149 edges, including only those ADR-ADR pairs found in at least 50% of NIDs. Comparison to the ADR-ADR network of non-NIDs revealed that the ADRs such as pruritus, pyrexia, thrombocytopenia, nervousness, asthenia, acute lymphocytic leukaemia were highly enriched in the NID network. Our ChEBI-based ontology analysis identified three benzimidazole NIDs (i.e., lansoprazole, omeprazole, and pantoprazole), which were associated with 43 ADRs. Based on ontology-based drug class effect definition, the benzimidazole drug group has a drug class effect on all of these 43 ADRs. Many of these 43 ADRs also exist in the enriched NID ADR network. Our Ontology of Adverse Events (OAE) classification further found that these 43 benzimidazole-related ADRs were distributed in many systems, primarily in behavioral and neurological, digestive, skin, and immune systems.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our study demonstrates that ontology-based literature mining and network analysis can efficiently identify and study specific group of drugs and their associated ADRs. Furthermore, our analysis of drug class effects identified 3 benzimidazole drugs sharing 43 ADRs, leading to new hypothesis generation and possible mechanism understanding of drug-induced peripheral neuropathy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13326-018-0185-x","type":"journal-article","created":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T03:20:45Z","timestamp":1528341645000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Ontology-based literature mining and class effect analysis of adverse drug reactions associated with neuropathy-inducing drugs"],"prefix":"10.1186","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0736-2149","authenticated-orcid":false,"given":"Junguk","family":"Hur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arzucan","family":"\u00d6zg\u00fcr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,7]]},"reference":[{"issue":"15","key":"185_CR1","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","volume":"279","author":"J Lazarou","year":"1998","unstructured":"Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279(15):1200\u20135.","journal-title":"JAMA"},{"issue":"5","key":"185_CR2","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/j.1365-2125.2011.04153.x","volume":"73","author":"P Warrer","year":"2012","unstructured":"Warrer P, Hansen EH, Juhl-Jensen L, Aagaard L. Using text-mining techniques in electronic patient records to identify ADRs from medicine use. Br J Clin Pharmacol. 2012;73(5):674\u201384.","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"185_CR3","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1055\/s-0038-1634945","volume":"32","author":"DA Lindberg","year":"1993","unstructured":"Lindberg DA, Humphreys BL, McCray AT. The unified medical language system. Methods Inf Med. 1993;32(4):281\u201391.","journal-title":"Methods Inf Med"},{"key":"185_CR4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/msb.2009.98","volume":"6","author":"M Kuhn","year":"2010","unstructured":"Kuhn M, Campillos M, Letunic I, Jensen LJ, Bork P. A side effect resource to capture phenotypic effects of drugs. Mol Syst Biol. 2010;6:343.","journal-title":"Mol Syst Biol"},{"key":"185_CR5","unstructured":"Leaman R, Wojtulewicz L, Sullivan R, Skariah A, Yang J, Gonzalez G. Towards internet-age pharmacovigilance: extracting adverse drug reactions from user posts to health-related social networks. In: Proceedings of the 2010 workshop on biomedical natural language proceessing. Stroudsburg: Association for Computational Linguistics; 2010. 117\u201325."},{"key":"185_CR6","first-page":"1019","volume":"2011","author":"A Nikfarjam","year":"2011","unstructured":"Nikfarjam A, Gonzalez GH. Pattern mining for extraction of mentions of adverse drug reactions from user comments. AMIA Annu Symp Proc. 2011;2011:1019\u201326.","journal-title":"AMIA Annu Symp Proc"},{"issue":"11","key":"185_CR7","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1002\/pds.3493","volume":"22","author":"H Gurulingappa","year":"2013","unstructured":"Gurulingappa H, Toldo L, Rajput AM, Kors JA, Taweel A, Tayrouz Y. Automatic detection of adverse events to predict drug label changes using text and data mining techniques. Pharmacoepidemiol Drug Saf. 2013;22(11):1189\u201394.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"185_CR8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2165\/00002018-199920020-00002","volume":"20","author":"EG Brown","year":"1999","unstructured":"Brown EG, Wood L, Wood S. The medical dictionary for regulatory activities (MedDRA). Drug Saf. 1999;20(2):109\u201317.","journal-title":"Drug Saf"},{"issue":"Database","key":"185_CR9","doi-asserted-by":"publisher","first-page":"D1035","DOI":"10.1093\/nar\/gkq1126","volume":"39","author":"C Knox","year":"2011","unstructured":"Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, et al. DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 2011;39(Database):D1035\u201341.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"185_CR10","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s40264-014-0189-0","volume":"37","author":"RD Boyce","year":"2014","unstructured":"Boyce RD, Ryan PB, Noren GN, Schuemie MJ, Reich C, Duke J, Tatonetti NP, Trifiro G, Harpaz R, Overhage JM, et al. Bridging islands of information to establish an integrated knowledge base of drugs and health outcomes of interest. Drug Saf. 2014;37(8):557\u201367.","journal-title":"Drug Saf"},{"key":"185_CR11","first-page":"177","volume":"2010","author":"JD Duke","year":"2010","unstructured":"Duke JD, Friedlin J. ADESSA: a real-time decision support Service for Delivery of semantically coded adverse drug event data. AMIA Annu Symp Proc. 2010;2010:177\u201381.","journal-title":"AMIA Annu Symp Proc"},{"issue":"10","key":"185_CR12","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s40264-014-0218-z","volume":"37","author":"R Harpaz","year":"2014","unstructured":"Harpaz R, Callahan A, Tamang S, Low Y, Odgers D, Finlayson S, Jung K, LePendu P, Shah NH. Text mining for adverse drug events: the promise, challenges, and state of the art. Drug Saf. 2014;37(10):777\u201390.","journal-title":"Drug Saf"},{"key":"185_CR13","first-page":"e114","volume":"3","author":"J Hur","year":"2014","unstructured":"Hur J, Guo AY, Loh WY, Feldman EL, Bai JPF. Integrated systems pharmacology analysis of clinical drug-induced peripheral neuropathy. CPT: pharmacomet syst pharmacol. 2014;3:e114.","journal-title":"CPT: pharmacomet syst pharmacol"},{"key":"185_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13326-016-0069-x","volume":"7","author":"A Guo","year":"2016","unstructured":"Guo A, Racz R, Hur J, Lin Y, Xiang Z, Zhao L, Rinder J, Jiang G, Zhu Q, He Y. Ontology-based collection, representation and analysis of drug-associated neuropathy adverse events. J Biomed Semantics. 2016;7:29.","journal-title":"J Biomed Semantics"},{"issue":"1","key":"185_CR15","doi-asserted-by":"publisher","first-page":"13819","DOI":"10.1038\/s41598-017-12580-4","volume":"7","author":"L Wang","year":"2017","unstructured":"Wang L, Li M, Xie J, Cao Y, Liu H, He Y. Ontology-based systematical representation and drug class effect analysis of package insert-reported adverse events associated with cardiovascular drugs used in China. Sci Rep. 2017;7(1):13819.","journal-title":"Sci Rep"},{"key":"185_CR16","volume-title":"The 1st International Conference on Biomedical Ontology (ICBO-2009): July 24\u201326 2009","author":"Y He","year":"2009","unstructured":"He Y, Cowell L, Diehl AD, Mobley HL, Peters B, Ruttenberg A, Scheuermann RH, Brinkman RR, Courtot M, Mungall C, et al. VO: Vaccine Ontology. In: The 1st International Conference on Biomedical Ontology (ICBO-2009): July 24\u201326 2009. Buffalo: Nature Precedings; 2009."},{"issue":"Suppl 2","key":"185_CR17","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1186\/2041-1480-2-S2-S8","volume":"2","author":"A Ozgur","year":"2011","unstructured":"Ozgur A, Xiang Z, Radev DR, He Y. Mining of vaccine-associated IFN-gamma gene interaction networks using the vaccine ontology. J Biomed Semantics. 2011;2(Suppl 2):S8.","journal-title":"J Biomed Semantics"},{"key":"185_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1471-2172-12-49","volume":"12","author":"J Hur","year":"2011","unstructured":"Hur J, Xiang Z, Feldman EL, He Y. Ontology-based Brucella vaccine literature indexing and systematic analysis of gene-vaccine association network. BMC Immunol. 2011;12:49.","journal-title":"BMC Immunol"},{"issue":"1","key":"185_CR19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/2041-1480-3-18","volume":"3","author":"J Hur","year":"2012","unstructured":"Hur J, Ozgur A, Xiang Z, He Y. Identification of fever and vaccine-associated gene interaction networks using ontology-based literature mining. Journal of biomedical semantics. 2012;3(1):18.","journal-title":"Journal of biomedical semantics"},{"issue":"6","key":"185_CR20","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1093\/bioinformatics\/btp049","volume":"25","author":"J Hur","year":"2009","unstructured":"Hur J, Schuyler AD, States DJ, Feldman EL. SciMiner: web-based literature mining tool for target identification and functional enrichment analysis. Bioinformatics. 2009;25(6):838\u201340.","journal-title":"Bioinformatics"},{"key":"185_CR21","doi-asserted-by":"publisher","first-page":"Article ID 4264","DOI":"10.1155\/2010\/426479","volume":"2010","author":"A Ozgur","year":"2010","unstructured":"Ozgur A, Xiang Z, Radev D, He Y. Literature-based discovery of IFN-\u03b3 and vaccine-mediated gene interaction networks. J Biomed Biotechnol. 2010;2010:Article ID 426479. (426413 pages)","journal-title":"J Biomed Biotechnol"},{"key":"185_CR22","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/978-1-61779-364-6_19","volume":"803","author":"P de Matos","year":"2012","unstructured":"de Matos P, Adams N, Hastings J, Moreno P, Steinbeck C. A database for chemical proteomics: ChEBI. Methods Mol Biol. 2012;803:273\u201396.","journal-title":"Methods Mol Biol"},{"key":"185_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/2041-1480-5-29","volume":"5","author":"Y He","year":"2014","unstructured":"He Y, Sarntivijai S, Lin Y, Xiang Z, Guo A, Zhang S, Jagannathan D, Toldo L, Tao C, Smith B. OAE: the ontology of adverse events. J Biomed Semantics. 2014;5:29.","journal-title":"J Biomed Semantics"},{"key":"185_CR24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/2041-1480-6-2","volume":"6","author":"J Hur","year":"2015","unstructured":"Hur J, Ozgur A, Xiang Z, He Y. Development and application of an interaction network ontology for literature mining of vaccine-associated gene-gene interactions. J Biomed Semantics. 2015;6:2.","journal-title":"J Biomed Semantics"},{"issue":"1","key":"185_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13326-017-0122-4","volume":"8","author":"J Hur","year":"2017","unstructured":"Hur J, Ozgur A, He Y. Ontology-based literature mining of E. coli vaccine-associated gene interaction networks. J Biomed Semantics. 2017;8(1):12.","journal-title":"J Biomed Semantics"},{"issue":"11","key":"185_CR26","first-page":"1396","volume":"50","author":"MJ Lu","year":"2015","unstructured":"Lu MJ, Liu YX. MedDRA and its applications in statistical analysis of adverse events. Yao Xue Xue Bao. 2015;50(11):1396\u2013401.","journal-title":"Yao Xue Xue Bao"},{"key":"185_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2018.1","volume":"5","author":"D Demner-Fushman","year":"2018","unstructured":"Demner-Fushman D, Shooshan SE, Rodriguez L, Aronson AR, Lang F, Rogers W, Roberts K, Tonning J. A dataset of 200 structured product labels annotated for adverse drug reactions. Sci Data. 2018;5:180001.","journal-title":"Sci Data"},{"issue":"21","key":"185_CR28","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1093\/bioinformatics\/btp517","volume":"25","author":"G Scardoni","year":"2009","unstructured":"Scardoni G, Petterlini M, Laudanna C. Analyzing biological network parameters with CentiScaPe. Bioinformatics. 2009;25(21):2857\u20139.","journal-title":"Bioinformatics"},{"issue":"175","key":"185_CR29","first-page":"1","volume":"3","author":"Z Xiang","year":"2010","unstructured":"Xiang Z, Courtot M, Brinkman RR, Ruttenberg A, He Y. OntoFox: web-based support for ontology reuse. BMC research notes. 2010;3(175):1\u201312.","journal-title":"BMC research notes"},{"issue":"Suppl 1","key":"185_CR30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s10278-007-9065-0","volume":"20","author":"DL Rubin","year":"2007","unstructured":"Rubin DL, Noy NF, Musen MA. Protege: a tool for managing and using terminology in radiology applications. J Digit Imaging. 2007;20(Suppl 1):34\u201346.","journal-title":"J Digit Imaging"},{"issue":"7","key":"185_CR31","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/ardp.201500464","volume":"349","author":"OO Ajani","year":"2016","unstructured":"Ajani OO, Aderohunmu DV, Ikpo CO, Adedapo AE, Olanrewaju IO. Functionalized Benzimidazole scaffolds: privileged Heterocycle for drug Design in Therapeutic Medicine. Arch Pharm. 2016;349(7):475\u2013506.","journal-title":"Arch Pharm"},{"issue":"6","key":"185_CR32","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1007\/s11894-000-0013-0","volume":"2","author":"AB Thomson","year":"2000","unstructured":"Thomson AB. Are the orally administered proton pump inhibitors equivalent? A comparison of lansoprazole, omeprazole, pantoprazole, and rabeprazole. Current gastroenterology reports. 2000;2(6):482\u201393.","journal-title":"Current gastroenterology reports"},{"issue":"5","key":"185_CR33","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/1099-1557(200009\/10)9:5<383::AID-PDS506>3.0.CO;2-W","volume":"9","author":"AA Claessens","year":"2000","unstructured":"Claessens AA, Heerdink ER, Van Eijk JT, Lamers CB, Leufkens HG. Safety review in 10,008 users of lansoprazole in daily practice. Pharmacoepidemiol Drug Saf. 2000;9(5):383\u201391.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"185_CR34","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2165\/00002018-200326020-00005","volume":"26","author":"LV Wilton","year":"2003","unstructured":"Wilton LV, Key C, Shakir SA. The pharmacovigilance of pantoprazole: the results of postmarketing surveillance on 11 541 patients in England. Drug Saf. 2003;26(2):121\u201332.","journal-title":"Drug Saf"},{"issue":"4","key":"185_CR35","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0016-5085(00)70135-1","volume":"118","author":"EC Klinkenberg-Knol","year":"2000","unstructured":"Klinkenberg-Knol EC, Nelis F, Dent J, Snel P, Mitchell B, Prichard P, Lloyd D, Havu N, Frame MH, Roman J, et al. Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa. Gastroenterology. 2000;118(4):661\u20139.","journal-title":"Gastroenterology"},{"issue":"8","key":"185_CR36","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1046\/j.1365-2036.2003.01550.x","volume":"17","author":"J Labenz","year":"2003","unstructured":"Labenz J, Petersen KU, Rosch W, Koelz HR. A summary of Food and Drug Administration-reported adverse events and drug interactions occurring during therapy with omeprazole, lansoprazole and pantoprazole. Aliment Pharmacol Ther. 2003;17(8):1015\u20139.","journal-title":"Aliment Pharmacol Ther"},{"key":"185_CR37","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1472-6947-10-66","volume":"10","author":"PM Nadkarni","year":"2010","unstructured":"Nadkarni PM, Darer JD. Determining correspondences between high-frequency MedDRA concepts and SNOMED: a case study. BMC Med Inform Decis Mak. 2010;10:66.","journal-title":"BMC Med Inform Decis Mak"}],"container-title":["Journal of Biomedical Semantics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13326-018-0185-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13326-018-0185-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13326-018-0185-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:24:39Z","timestamp":1790036679000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13326-018-0185-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,7]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["185"],"URL":"https:\/\/doi.org\/10.1186\/s13326-018-0185-x","relation":{},"ISSN":["2041-1480"],"issn-type":[{"value":"2041-1480","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,7]]},"assertion":[{"value":"6 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","label":"Publisher\u2019s Note","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"17"}}